547 related articles for article (PubMed ID: 19402770)
1. Donepezil in the treatment of patients with Alzheimer's disease.
Tsuno N
Expert Rev Neurother; 2009 May; 9(5):591-8. PubMed ID: 19402770
[TBL] [Abstract][Full Text] [Related]
2. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
Passmore AP; Bayer AJ; Steinhagen-Thiessen E
J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
[TBL] [Abstract][Full Text] [Related]
3. Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials.
Winblad B; Black SE; Homma A; Schwam EM; Moline M; Xu Y; Perdomo CA; Swartz J; Albert K
Curr Med Res Opin; 2009 Nov; 25(11):2577-87. PubMed ID: 19735164
[TBL] [Abstract][Full Text] [Related]
4. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.
Bullock R; Bergman H; Touchon J; Gambina G; He Y; Nagel J; Lane R
Curr Med Res Opin; 2006 Mar; 22(3):483-94. PubMed ID: 16574032
[TBL] [Abstract][Full Text] [Related]
5. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
[TBL] [Abstract][Full Text] [Related]
6. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
Bullock R; Touchon J; Bergman H; Gambina G; He Y; Rapatz G; Nagel J; Lane R
Curr Med Res Opin; 2005 Aug; 21(8):1317-27. PubMed ID: 16083542
[TBL] [Abstract][Full Text] [Related]
7. Donepezil for Alzheimer's disease.
Benjamin B; Burns A
Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
[TBL] [Abstract][Full Text] [Related]
9. Cholinesterase inhibitors in the treatment of dementia.
Ellis JM
J Am Osteopath Assoc; 2005 Mar; 105(3):145-58. PubMed ID: 15863734
[TBL] [Abstract][Full Text] [Related]
10. Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: implications for early diagnosis and treatment.
Molinuevo JL; Berthier ML; Rami L
Arch Gerontol Geriatr; 2011; 52(1):18-22. PubMed ID: 19948364
[TBL] [Abstract][Full Text] [Related]
11. [[Donepezil : a new option in the treatment of Alzheimer's disease] ONEPA].
Azanza JR; Sádaba B; Quetglas EG; Escolar M
Rev Med Univ Navarra; 1998; 42(2):109-18. PubMed ID: 10420948
[No Abstract] [Full Text] [Related]
12. Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep.
Mizuno S; Kameda A; Inagaki T; Horiguchi J
Psychiatry Clin Neurosci; 2004 Dec; 58(6):660-5. PubMed ID: 15601392
[TBL] [Abstract][Full Text] [Related]
13. Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease.
Seripa D; Bizzarro A; Pilotto A; D'onofrio G; Vecchione G; Gallo AP; Cascavilla L; Paris F; Grandone E; Mecocci P; Santini SA; Masullo C; Pilotto A
Pharmacogenet Genomics; 2011 Apr; 21(4):225-30. PubMed ID: 20859244
[TBL] [Abstract][Full Text] [Related]
14. Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.
Feldman HH; Schmitt FA; Olin JT;
Alzheimer Dis Assoc Disord; 2006; 20(4):263-8. PubMed ID: 17132971
[TBL] [Abstract][Full Text] [Related]
15. Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease.
Blesa R; Bullock R; He Y; Bergman H; Gambina G; Meyer J; Rapatz G; Nagel J; Lane R
Pharmacogenet Genomics; 2006 Nov; 16(11):771-4. PubMed ID: 17047484
[TBL] [Abstract][Full Text] [Related]
16. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?
Stiles MM; Martin S; Persons RK
J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040
[No Abstract] [Full Text] [Related]
17. A 10-year perspective on donepezil.
Cheewakriengkrai L; Gauthier S
Expert Opin Pharmacother; 2013 Feb; 14(3):331-8. PubMed ID: 23316713
[TBL] [Abstract][Full Text] [Related]
18. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic standards in Alzheimer disease.
Doody RS
Alzheimer Dis Assoc Disord; 1999 Nov; 13 Suppl 2():S20-6. PubMed ID: 10622675
[TBL] [Abstract][Full Text] [Related]
20. Donepezil hydrochloride: a treatment drug for Alzheimer's disease.
Sugimoto H
Chem Rec; 2001; 1(1):63-73. PubMed ID: 11893059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
